JVRS-100, a seasonal influenza vaccine for the elderly from Juvaris BioTherapeutics, Inc is currently undergoing human studies. Juvaris BioTherapeutics, Inc has begun enrolling patients in a Phase 2 clinical trial of its lead compound, JVRS-100, as an adjuvant for seasonal influenza vaccines in the elderly population. “There is a significant need to ...